https://www.prnewswire.co.uk/news-releases/piramal-healthcare-limited-acquires-molecular-imaging-development-portfolio-of-bayer-pharma-147507405.html
Piramal Healthcare Limited Acquires Molecular Imaging Development Portfolio of Bayer Pharma
/PRNewswire/ -- Piramal Healthcare Limited [NSE: PIRHEALTH, BSE: 500302] ("Piramal"), announced that it has signed an agreement to acquire worldwide rights...
piramal healthcaremolecular imagingdevelopment portfoliolimitedacquires